Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease

作者: Joo Hae Kim , Ho Il Yoon , Yeon-Mok Oh , Seong Yong Lim , Ji-Hyun Lee

DOI: 10.2147/COPD.S87766

关键词:

摘要: Background Since the Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups A-D were introduced, lung function changes according to group have been evaluated rarely. Objective We investigated rate of decline in annual patients categorized 2014 GOLD guidelines. Methods Patients with COPD included Korean (KOLD) prospective study, who underwent yearly postbronchodilator spirometry at least three times, included. The main outcome was forced expiratory volume 1 second (FEV1), which analyzed by random-slope and random-intercept mixed linear regression. Results A total 175 participants No significant FEV1 observed between (-34.4±7.9 [group A]; -26.2±9.4 B]; -22.7±16.0 C]; -24.0±8.7 mL/year D]) (P=0.79). less symptoms (-32.3±7.2 vs -25.0±6.5 mL/year) (P=0.44) low risk (-31.0±6.1 -23.6±7.7 baseline showed a more rapid FEV1, but trends not statistically significant. However, stages classified significantly related decline. Conclusion There no difference rates groups. Prior classification using predicts better than does new classification.

参考文章(18)
Joan B Soriano, Inmaculada Alfageme, Pere Almagro, Ciro Casanova, Cristobal Esteban, Juan J Soler-Cataluña, Juan P de Torres, Pablo Martinez-Camblor, Marc Miravitlles, Bartolome R Celli, Jose M Marin, None, Distribution and Prognostic Validity of the New Global Initiative for Chronic Obstructive Lung Disease Grading Classification Chest. ,vol. 143, pp. 694- 702 ,(2013) , 10.1378/CHEST.12-1053
Bartolomé R. Celli, Nicola E. Thomas, Julie A. Anderson, Gary T. Ferguson, Christine R. Jenkins, Paul W. Jones, Jørgen Vestbo, Katharine Knobil, Julie C. Yates, Peter M. A. Calverley, Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease Results from the TORCH Study American Journal of Respiratory and Critical Care Medicine. ,vol. 178, pp. 332- 338 ,(2008) , 10.1164/RCCM.200712-1869OC
Cara Cassino & Steven Kesten Marc Decramer, Bartolome Celli, Donald P. Tashkin, Romain A. Pauwels, Deborah Burkhart, None, Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift Trial COPD: Journal of Chronic Obstructive Pulmonary Disease. ,vol. 1, pp. 303- 312 ,(2004) , 10.1081/COPD-200026934
Tai Sun Park, Jae Seung Lee, Joon Beom Seo, Yoonki Hong, Jung-Wan Yoo, Byung Ju Kang, Sei Won Lee, Yeon-Mok Oh, Sang-Do Lee, None, Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study Tuberculosis and Respiratory Diseases. ,vol. 76, pp. 169- 174 ,(2014) , 10.4046/TRD.2014.76.4.169
Marc Decramer, Bartolome Celli, Steven Kesten, Theodore Lystig, Sunil Mehra, Donald P Tashkin, Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial The Lancet. ,vol. 374, pp. 1171- 1178 ,(2009) , 10.1016/S0140-6736(09)61298-8
Claudio Tantucci, Denise Modina, Lung function decline in COPD International Journal of Chronic Obstructive Pulmonary Disease. ,vol. 7, pp. 95- 99 ,(2012) , 10.2147/COPD.S27480
P. W. Jones, G. Brusselle, R. W. Dal Negro, M. Ferrer, P. Kardos, M. L. Levy, T. Perez, J. J. Soler Cataluna, T. van der Molen, L. Adamek, N. Banik, Properties of the COPD assessment test in a cross-sectional European study European Respiratory Journal. ,vol. 38, pp. 29- 35 ,(2011) , 10.1183/09031936.00177210
Morten Dahl, Børge Grønne Nordestgaard, Peter Lange, Jacob Louis Marott, Jørgen Vestbo, Kim Rose Olsen, Truls Sylvan Ingebrigtsen, Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. American Journal of Respiratory and Critical Care Medicine. ,vol. 186, pp. 975- 981 ,(2012) , 10.1164/RCCM.201207-1299OC
Thomas Ringbaek, Gerd Martinez, Peter Lange, A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation COPD: Journal of Chronic Obstructive Pulmonary Disease. ,vol. 9, pp. 12- 15 ,(2012) , 10.3109/15412555.2011.630248
Lucas M A Goossens, Inge Leimer, Norbert Metzdorf, Karin Becker, Maureen P M H Rutten-van Mölken, Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial BMC Pulmonary Medicine. ,vol. 14, pp. 163- 163 ,(2014) , 10.1186/1471-2466-14-163